longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Silver breaks above $70, Novo Nordisk surges 9% on obesity pill approval. Wall Street rises, S&P 500 at 6,900, with 4.3% US GDP growth in Q3. Fed easing expectations decrease to 15%.

Unusual Whales
Dec 23, 2025 at 06:22 PM
On Wednesday, Wall Street saw modest gains as investors anticipated a strong year-end period. By midday in New York, the S&P 500 rose to around 6,900, nearing October’s record of 6,920. The Nasdaq 100 also increased by 0.4% while the Dow Jones Industrial Average went up by 0.3%. However, small caps did not perform as well, with the Russell 2000 down by approximately 0.6%. The day was influenced by the release of better-than-expected U.S. GDP data. In the third quarter, the GDP grew at a 4.3% annualized rate, surpassing the estimated 3.3% and being the quickest growth in two years. As a result, traders adjusted their expectations for Federal Reserve easing. There is now a 15% likelihood of a 25-basis-point cut in late January, reduced from the previous day’s 20%.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Mar 9, 2026 at 04:15 PMHandshake and reconciliation! Novo Nordisk withdraws lawsuit, Wegovy officially launches on the Hims & Hers platform
  • Feb 24, 2026 at 01:55 PMNovo Nordisk will significantly reduce the price of its weight loss drug in the U.S. next year, with a maximum reduction…
  • Feb 24, 2026 at 11:58 AMNovo Nordisk UBT251 shows impressive phase II clinical data in China, with a weight loss effect of nearly 20%
  • Feb 23, 2026 at 01:57 PMGlobal news you need to know before Monday's U.S. stock market opens
  • Feb 9, 2026 at 09:04 PMNovo Nordisk's weight loss drug advertisement was deemed "false or misleading" by the FDA, and the stock price hit a new…
Novo Nordisk AS

Novo Nordisk AS

NVO.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI